Literature DB >> 27776933

Amidst the excitement: A cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinoma.

Shrujal S Baxi1, Lara A Dunn2, Barbara A Burtness3.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27776933     DOI: 10.1016/j.oraloncology.2016.10.007

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  8 in total

1.  New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Authors:  Andrea Alberti; Luigi Lorini; Marco Ravanelli; Francesco Perri; Marie Vinches; Paolo Rondi; Chiara Romani; Paolo Bossi
Journal:  Vaccines (Basel)       Date:  2022-06-01

2.  Immunotherapy in head and neck cancer: aiming at EXTREME precision.

Authors:  Petr Szturz; Jan B Vermorken
Journal:  BMC Med       Date:  2017-06-02       Impact factor: 8.775

Review 3.  Immunotherapy for Head and Neck Squamous Cell Carcinoma.

Authors:  Jessica Moskovitz; Jennifer Moy; Robert L Ferris
Journal:  Curr Oncol Rep       Date:  2018-03-03       Impact factor: 5.075

Review 4.  Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma.

Authors:  Valerie Cristina; Ruth Gabriela Herrera-Gómez; Petr Szturz; Vittoria Espeli; Marco Siano
Journal:  Int J Mol Sci       Date:  2019-10-30       Impact factor: 5.923

5.  Patterns of response in metastatic NSCLC during PD-1 or PD-L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria.

Authors:  Hongge Liang; Yan Xu; Minjiang Chen; Wei Zhong; Mengzhao Wang; Jing Zhao
Journal:  Thorac Cancer       Date:  2020-03-04       Impact factor: 3.500

Review 6.  Hyperprogressive Disease in Malignant Carcinoma With Immune Checkpoint Inhibitor Use: A Review.

Authors:  Xiaojun Liu; Liang Qiao
Journal:  Front Nutr       Date:  2022-03-25

Review 7.  Head and neck cancer: improving outcomes with a multidisciplinary approach.

Authors:  Cristiana Lo Nigro; Nerina Denaro; Anna Merlotti; Marco Merlano
Journal:  Cancer Manag Res       Date:  2017-08-18       Impact factor: 3.989

8.  The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy.

Authors:  Wenxiao Jia; Qianqian Gao; Anqin Han; Hui Zhu; Jinming Yu
Journal:  Cancer Biol Med       Date:  2019-11       Impact factor: 4.248

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.